Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE)
CUSIP: 22978P106
Q2 2023 13F Holders as of 30 Jun 2023
- Type / Class
- Equity / Common Stock, $0.001 par value per share
- Shares outstanding
- 43,411,663
- Total 13F shares
- 13,849,849
- Share change
- +1,799,013
- Total reported value
- $50,545,862
- Put/Call ratio
- 49%
- Price per share
- $3.65
- Number of holders
- 77
- Value change
- +$6,687,288
- Number of buys
- 51
- Number of sells
- 22
Quarterly Holders Quick Answers
What is CUSIP 22978P106?
CUSIP 22978P106 identifies CUE - Cue Biopharma, Inc. - Common Stock, $0.001 par value per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 22978P106:
Top shareholders of CUE - Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Slate Path Capital LP |
13F
|
Company |
5.5%
|
2,402,455
|
$8,576,764 | — | 31 Mar 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.8%
|
1,653,596
|
$5,903,338 | — | 31 Mar 2023 | |
| Prosight Management, LP |
13F
|
Company |
2.7%
|
1,151,855
|
$4,112,122 | — | 31 Mar 2023 | |
| Bleichroeder LP |
13F
|
Company |
1.7%
|
755,028
|
$2,695,450 | — | 31 Mar 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
1.5%
|
664,426
|
$2,372,000 | — | 31 Mar 2023 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.3%
|
545,624
|
$1,947,824 | — | 31 Mar 2023 | |
| Cameron Gray |
3/4/5
|
Director |
—
class O/S missing
|
687,049
|
$1,896,255 | — | 14 Jun 2022 | |
| Mark E. Strome |
13D/G
|
— |
5%
|
2,166,242
|
$1,862,968 | $0 | 14 Nov 2022 | |
| Robertson Stephens Wealth Management, LLC |
13F
|
Company |
1.1%
|
478,500
|
$1,708,245 | — | 31 Mar 2023 | |
| Monaco Asset Management SAM |
13F
|
Company |
1.1%
|
466,345
|
$1,664,852 | — | 31 Mar 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1%
|
452,768
|
$1,616,381 | — | 31 Mar 2023 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.79%
|
344,612
|
$1,230,000 | — | 31 Mar 2023 | |
| SILVERARC CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.71%
|
306,278
|
$1,093,412 | — | 31 Mar 2023 | |
| ADVISORY RESEARCH INC |
13F
|
Company |
0.59%
|
257,225
|
$918,293 | — | 31 Mar 2023 | |
| Carlson Capital, L.P. |
13F
|
Company |
0.59%
|
254,036
|
$906,909 | — | 31 Mar 2023 | |
| Sigma Planning Corp |
13F
|
Company |
0.51%
|
220,889
|
$788,574 | — | 31 Mar 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.39%
|
167,495
|
$597,957 | — | 31 Mar 2023 | |
| P.A.W. CAPITAL CORP |
13F
|
Company |
0.35%
|
150,000
|
$535,500 | — | 31 Mar 2023 | |
| STIFEL FINANCIAL CORP |
13F
|
Company |
0.34%
|
146,464
|
$522,879 | — | 31 Mar 2023 | |
| STATE STREET CORP |
13F
|
Company |
0.33%
|
141,153
|
$503,916 | — | 31 Mar 2023 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.31%
|
132,535
|
$473,150 | — | 31 Mar 2023 | |
| Voss Capital, LP |
13F
|
Company |
0.29%
|
125,000
|
$446,250 | — | 31 Mar 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.24%
|
105,659
|
$377,202 | — | 31 Mar 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.23%
|
98,925
|
$353,162 | — | 31 Mar 2023 | |
| Nantahala Capital Management, LLC |
13F
|
Company |
0.21%
|
93,297
|
$333,070 | — | 31 Mar 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.18%
|
78,300
|
$279,531 | — | 31 Mar 2023 | |
| HighTower Advisors, LLC |
13F
|
Company |
0.18%
|
76,110
|
$272,000 | — | 31 Mar 2023 | |
| Good Life Advisors, LLC |
13F
|
Company |
0.18%
|
76,000
|
$271,320 | — | 31 Mar 2023 | |
| Parallax Volatility Advisers, L.P. |
13F
|
Company |
0.17%
|
75,000
|
$267,750 | — | 31 Mar 2023 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.17%
|
73,111
|
$261,000 | — | 31 Mar 2023 | |
| Annandale Capital, LLC |
13F
|
Company |
0.15%
|
65,000
|
$232,000 | — | 31 Mar 2023 | |
| CHANNEL WEALTH LLC |
13F
|
Company |
0.14%
|
60,050
|
$214,379 | — | 31 Mar 2023 | |
| UBS Group AG |
13F
|
Company |
0.13%
|
58,029
|
$207,163 | — | 31 Mar 2023 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.12%
|
51,326
|
$183,233 | — | 31 Mar 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.12%
|
51,100
|
$182,000 | — | 31 Mar 2023 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.09%
|
40,320
|
$143,942 | — | 31 Mar 2023 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.08%
|
33,100
|
$118,167 | — | 31 Mar 2023 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.06%
|
26,974
|
$96,297 | — | 31 Mar 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.06%
|
26,084
|
$93,120 | — | 31 Mar 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.05%
|
21,287
|
$75,995 | — | 31 Mar 2023 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.05%
|
20,233
|
$72,232 | — | 31 Mar 2023 | |
| SeaCrest Wealth Management, LLC |
13F
|
Company |
0.03%
|
14,000
|
$49,980 | — | 31 Mar 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.03%
|
13,924
|
$49,709 | — | 31 Mar 2023 | |
| ETF MANAGERS GROUP, LLC |
13F
|
Company |
0.03%
|
13,528
|
$48,295 | — | 31 Mar 2023 | |
| OCCUDO QUANTITATIVE STRATEGIES LP |
13F
|
Company |
0.03%
|
13,137
|
$46,899 | — | 31 Mar 2023 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0.03%
|
11,586
|
$41,000 | — | 31 Mar 2023 | |
| LPL Financial LLC |
13F
|
Company |
0.02%
|
10,570
|
$37,735 | — | 31 Mar 2023 | |
| Beacon Pointe Advisors, LLC |
13F
|
Company |
0.02%
|
10,000
|
$35,700 | — | 31 Mar 2023 | |
| BARCLAYS PLC |
13F
|
Company |
0.01%
|
6,029
|
$21,524 | — | 31 Mar 2023 | |
| Newbridge Financial Services Group, Inc. |
13F
|
Company |
0.01%
|
5,000
|
$17,850 | — | 31 Mar 2023 |
Institutional Holders of Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) as of Q2 2023
As of 30 Jun 2023,
Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) was held by
77 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,849,849 shares.
The largest 10 holders included
Slate Path Capital LP, BlackRock Inc., VANGUARD GROUP INC, Bleichroeder LP, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, DIMENSIONAL FUND ADVISORS LP, Robertson Stephens Wealth Management, LLC, SILVERARC CAPITAL MANAGEMENT, LLC, and Monaco Asset Management SAM.
This page lists
77
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2023 vs Q1 2023 Across Filers
Q1 2023 holders
62
Q2 2023 holders
77
Holder diff
15
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 Value $ | Q2 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.